|
Volumn 5, Issue 1, 2002, Pages 28-31
|
Dementia in patients with mental retardation/developmental disabilities
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALPHA TOCOPHEROL;
ANTIDEPRESSANT AGENT;
CHOLINESTERASE INHIBITOR;
CITALOPRAM;
DONEPEZIL;
ESTROGEN;
GALANTAMINE;
IBUPROFEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
RISPERIDONE;
RIVASTIGMINE;
SERTRALINE;
TRAZODONE;
AGNOSIA;
ALZHEIMER DISEASE;
AMNESIA;
APHASIA;
APRAXIA;
CAREGIVER;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONFUSION;
DELUSION;
DEMENTIA;
DEPRESSION;
DEVELOPMENTAL DISORDER;
DIARRHEA;
DISEASE PREDISPOSITION;
DOSE CALCULATION;
DOWN SYNDROME;
DRUG EFFECT;
DRUG MONITORING;
DRUG PREFERENCE;
DRUG TOLERABILITY;
ENVIRONMENTAL FACTOR;
GAIT DISORDER;
HALLUCINATION;
HIGH RISK PATIENT;
HUMAN;
LABORATORY TEST;
MANIA;
MENTAL DEFICIENCY;
NAUSEA AND VOMITING;
NEUROPSYCHOLOGICAL TEST;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOPHYSIOLOGY;
PATIENT GUIDANCE;
PHYSICAL EXAMINATION;
PRACTICE GUIDELINE;
PSYCHOLOGIC TEST;
STROKE;
SYMPTOMATOLOGY;
TREMOR;
VASCULAR DISEASE;
|
EID: 0036189413
PISSN: 10573291
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (1)
|
References (13)
|